|
EP0590058B1
(en)
|
1991-06-14 |
2003-11-26 |
Genentech, Inc. |
HUMANIZED Heregulin ANTIBODy
|
|
US7060808B1
(en)
|
1995-06-07 |
2006-06-13 |
Imclone Systems Incorporated |
Humanized anti-EGF receptor monoclonal antibody
|
|
US6576232B1
(en)
|
1998-04-03 |
2003-06-10 |
The Penn State Research Foundation |
IL13 mutants
|
|
US6723538B2
(en)
|
1999-03-11 |
2004-04-20 |
Micromet Ag |
Bispecific antibody and chemokine receptor constructs
|
|
EP1206288B1
(en)
*
|
1999-08-02 |
2007-01-10 |
The Regents Of The University Of Michigan |
Targeted fiberless radiative effectors
|
|
JP4863150B2
(ja)
*
|
2000-08-30 |
2012-01-25 |
ザ・ペン・ステート・リサーチ・ファンデーション |
インターロイキン13のアミノ酸置換変異体
|
|
US20090257994A1
(en)
|
2001-04-30 |
2009-10-15 |
City Of Hope |
Chimeric immunoreceptor useful in treating human cancers
|
|
US7514537B2
(en)
|
2001-04-30 |
2009-04-07 |
City Of Hope |
Chimeric immunoreceptor useful in treating human gliomas
|
|
AU2004242846A1
(en)
|
2003-05-31 |
2004-12-09 |
Micromet Ag |
Pharmaceutical compositions comprising bispecific anti-CD3, anti-CD19 antibody constructs for the treatment of B-cell related disorders
|
|
US7902338B2
(en)
|
2003-07-31 |
2011-03-08 |
Immunomedics, Inc. |
Anti-CD19 antibodies
|
|
US8076459B2
(en)
|
2003-10-16 |
2011-12-13 |
Micromet Ag |
Multispecfic deimmunized CD3-binders
|
|
US7435596B2
(en)
|
2004-11-04 |
2008-10-14 |
St. Jude Children's Research Hospital, Inc. |
Modified cell line and method for expansion of NK cell
|
|
US20130266551A1
(en)
|
2003-11-05 |
2013-10-10 |
St. Jude Children's Research Hospital, Inc. |
Chimeric receptors with 4-1bb stimulatory signaling domain
|
|
BRPI0507649A
(pt)
|
2004-02-16 |
2007-07-10 |
Micromet Ag |
molécula de ligação biespecìfica, seqüência de ácido nucléico, vetor, processo para a produção da molécula de ligação biespecìfica, composição, uso da molécula de ligação biespecìfica na preparação da composição farmacêutica, e kit
|
|
JP5014988B2
(ja)
|
2004-07-16 |
2012-08-29 |
マイクロメット アクツィエン ゲゼルシャフト |
発現増強ポリペプチド
|
|
US20090252681A1
(en)
|
2005-10-11 |
2009-10-08 |
Ablynx N.V. |
Nanobodies and Polypeptides Against EGFR and IGF-IR
|
|
WO2007042289A2
(en)
|
2005-10-11 |
2007-04-19 |
Ablynx N.V. |
Nanobodies™ and polypeptides against egfr and igf-ir
|
|
DK1940461T3
(da)
|
2005-11-02 |
2014-03-31 |
Univ Duke |
Samtidig kemoterapi og immunterapi
|
|
US20070264687A1
(en)
|
2005-12-15 |
2007-11-15 |
Min-Yuan Chou |
Recombinant triplex scaffold-based polypeptides
|
|
WO2008119565A2
(en)
|
2007-04-03 |
2008-10-09 |
Micromet Ag |
Cross-species-specific binding domain
|
|
EP2190861A4
(en)
|
2007-08-22 |
2011-03-30 |
Univ California |
ACTIVE BINDING POLYPEPTIDES AND METHOD FOR THEIR IDENTIFICATION AND USE
|
|
CA2735456C
(en)
|
2008-08-26 |
2021-11-16 |
City Of Hope |
Method and compositions for enhanced anti-tumor effector functioning of t cells
|
|
JP5676968B2
(ja)
|
2010-08-12 |
2015-02-25 |
キヤノン株式会社 |
画像処理装置及び画像処理方法
|
|
EP3115373B1
(en)
|
2010-09-08 |
2019-08-28 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
Chimeric antigen receptors with an optimized hinge region
|
|
WO2012050374A2
(en)
|
2010-10-13 |
2012-04-19 |
Innocell, Inc. |
Immunotherapy for solid tumors
|
|
JP5908972B2
(ja)
|
2011-04-07 |
2016-04-26 |
アムジエン・インコーポレーテツド |
新規な抗原結合タンパク質
|
|
AR090263A1
(es)
|
2012-03-08 |
2014-10-29 |
Hoffmann La Roche |
Terapia combinada de anticuerpos contra el csf-1r humano y las utilizaciones de la misma
|
|
IN2014MN02293A
(cg-RX-API-DMAC10.html)
|
2012-04-20 |
2015-08-07 |
Emergent Product Dev Seattle |
|
|
US20130280220A1
(en)
|
2012-04-20 |
2013-10-24 |
Nabil Ahmed |
Chimeric antigen receptor for bispecific activation and targeting of t lymphocytes
|
|
KR20150029714A
(ko)
|
2012-07-13 |
2015-03-18 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
이중특이적 항체의 공-도입에 의한 car 세포의 활성 증강
|
|
AU2013302696B9
(en)
|
2012-08-14 |
2018-08-09 |
Ibc Pharmaceuticals, Inc. |
T-cell redirecting bispecific antibodies for treatment of disease
|
|
KR20210090298A
(ko)
|
2012-10-30 |
2021-07-19 |
에스퍼란스 파마슈티컬스, 인코포레이티드 |
항체/약물 컨쥬게이트 및 이의 사용 방법
|
|
US9562110B2
(en)
|
2012-11-21 |
2017-02-07 |
Wuhan Yzy Biopharma Co., Ltd. |
Bispecific antibody
|
|
SG11201505896YA
(en)
|
2013-02-20 |
2015-09-29 |
Novartis Ag |
Treatment of cancer using humanized anti-egfrviii chimeric antigen receptor
|
|
IL298125A
(en)
|
2013-02-26 |
2023-01-01 |
Memorial Sloan Kettering Cancer Center |
Preparations and methods for immunotherapy
|
|
US20160017058A1
(en)
|
2013-03-14 |
2016-01-21 |
The California Institute For Biomedical Research |
Bispecific antibodies and uses thereof
|
|
WO2014172584A1
(en)
|
2013-04-17 |
2014-10-23 |
Baylor College Of Medicine |
IMMUNOSUPPRESSIVE TGF-β SIGNAL CONVERTER
|
|
CA2912389C
(en)
|
2013-06-10 |
2020-01-28 |
The General Hospital Corporation D/B/A Massachusetts General Hospital |
Methods and compositions for reducing immunosupression by tumor cells
|
|
EP2930188A1
(en)
|
2014-04-13 |
2015-10-14 |
Affimed Therapeutics AG |
Trifunctional antigen-binding molecule
|
|
WO2015168474A1
(en)
|
2014-04-30 |
2015-11-05 |
President And Fellows Of Harvard College |
Fusion proteins for treating cancer and related methods
|
|
EP3613433B1
(en)
|
2014-05-30 |
2022-01-05 |
Shanghai Henlius Biotech, Inc. |
Anti-epidermal growth factor receptor (egfr) antibodies
|
|
CN112546230A
(zh)
|
2014-07-09 |
2021-03-26 |
博笛生物科技有限公司 |
用于治疗癌症的联合治疗组合物和联合治疗方法
|
|
PL3177643T3
(pl)
|
2014-08-04 |
2019-09-30 |
F.Hoffmann-La Roche Ag |
Dwuswoiste cząsteczki wiążące antygen aktywujące komórki T
|
|
KR20240056629A
(ko)
|
2014-09-28 |
2024-04-30 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
자극성 및 비자극성 골수성 세포의 조절
|
|
CA3081058C
(en)
|
2015-01-16 |
2024-02-20 |
Academia Sinica |
Linker units and their uses in configuring pharmaceutical molecules
|
|
EP3250611B1
(en)
|
2015-01-26 |
2021-04-21 |
The University of Chicago |
Car t-cells recognizing cancer-specific il 13r-alpha2
|
|
MA41433A
(fr)
|
2015-01-26 |
2017-12-05 |
Baylor College Medicine |
Cellules immunitaires universelles pour l'immunothérapie anticancéreuse
|
|
WO2016123675A1
(en)
|
2015-02-05 |
2016-08-11 |
The University Of Queensland |
Targeting constructs for delivery of payloads
|
|
WO2016146894A1
(en)
|
2015-03-17 |
2016-09-22 |
Tilt Biotherapeutics Oy |
Oncolytic adenoviruses coding for bi-specific antibodies and methods and uses related thereto
|
|
WO2016154585A1
(en)
*
|
2015-03-26 |
2016-09-29 |
Charles Sentman |
Anti-mica antigen binding fragments, fusion molecules, cells which express and methods of using
|
|
CN104829730A
(zh)
|
2015-04-14 |
2015-08-12 |
苏静 |
一种能联合免疫细胞增强肿瘤杀伤能力的双特异性抗体及其制备方法和应用
|
|
EP3778640A1
(en)
|
2015-05-01 |
2021-02-17 |
Genentech, Inc. |
Masked anti-cd3 antibodies and methods of use
|
|
ES2984656T3
(es)
|
2015-05-13 |
2024-10-30 |
Ablynx Nv |
Polipéptidos que reclutan linfocitos T en función de la reactividad a CD3
|
|
TWI744242B
(zh)
|
2015-07-31 |
2021-11-01 |
德商安美基研究(慕尼黑)公司 |
Egfrviii及cd3抗體構築體
|
|
IL292504B2
(en)
|
2015-10-20 |
2024-01-01 |
Kite Pharma Inc |
-methods of preparing t cells for t cell therapy
|
|
HUE054131T2
(hu)
|
2015-11-19 |
2021-08-30 |
Revitope Ltd |
Funkcionális ellenanyag-fragmens-komplementáció nemkívánatos sejtek elpusztítására szolgáló kétkomponensû rendszerben
|
|
GB201521389D0
(en)
|
2015-12-03 |
2016-01-20 |
Ucb Biopharma Sprl |
Method
|
|
CN109071632B
(zh)
|
2016-02-05 |
2022-12-30 |
奥里尼斯生物科学私人有限公司 |
靶向性治疗剂及其用途
|
|
JP7189019B2
(ja)
|
2016-02-05 |
2022-12-13 |
シティ・オブ・ホープ |
中枢神経系の癌の治療のための操作されたt細胞の投与
|
|
AU2017229687A1
(en)
|
2016-03-08 |
2018-09-20 |
Takeda Pharmaceutical Company Limited |
Inducible binding proteins and methods of use
|
|
US11291721B2
(en)
|
2016-03-21 |
2022-04-05 |
Marengo Therapeutics, Inc. |
Multispecific and multifunctional molecules and uses thereof
|
|
SG11201808196UA
(en)
|
2016-03-31 |
2018-10-30 |
Neon Therapeutics Inc |
Neoantigens and methods of their use
|
|
ES3056995T3
(en)
|
2016-04-13 |
2026-02-25 |
Vivia Biotech Sl |
Ex vivo bite-activated t cells
|
|
US11596699B2
(en)
|
2016-04-29 |
2023-03-07 |
CureVac SE |
RNA encoding an antibody
|
|
EP3484455A2
(en)
|
2016-07-15 |
2019-05-22 |
Novartis AG |
Treatment and prevention of cytokine release syndrome using a chimeric antigen receptor in combination with a kinase inhibitor
|
|
WO2018014260A1
(en)
|
2016-07-20 |
2018-01-25 |
Nanjing Legend Biotech Co., Ltd. |
Multispecific antigen binding proteins and methods of use thereof
|
|
EP3500696A4
(en)
|
2016-08-16 |
2020-04-08 |
Bluebird Bio, Inc. |
VARIANTS OF IL-10 ALPHA RECEPTOR HOMING ENDONUCLEASE, COMPOSITIONS AND METHODS OF USE
|
|
US20190262398A1
(en)
|
2016-08-23 |
2019-08-29 |
Bluebird Bio, Inc. |
Tim3 homing endonuclease variants, compositions, and methods of use
|
|
KR102491752B1
(ko)
|
2016-08-29 |
2023-01-26 |
싸이오서스 테라퓨틱스 엘티디. |
이중특이성 T 세포 세포 관여자(BiTE)가 보강된 아데노바이러스
|
|
CN109983027A
(zh)
|
2016-10-20 |
2019-07-05 |
细胞基因公司 |
基于cereblon的可异二聚化嵌合抗原受体
|
|
AU2017368248A1
(en)
|
2016-11-30 |
2019-06-06 |
Intrexon Corporation |
Steroid administration and immunotherapy
|
|
CA3049652A1
(en)
|
2017-01-10 |
2018-07-19 |
Intrexon Corporation |
Modulating expression of polypeptides via new gene switch expression systems
|
|
CR20190408A
(es)
|
2017-02-02 |
2020-01-31 |
Amgen Inc |
Composición farmacéutica de bajo ph que comprende construcciones de anticuerpos que activan linfocitos t antecedentes
|
|
EP4759318A2
(en)
*
|
2017-04-14 |
2026-06-17 |
The General Hospital Corporation |
Chimeric antigen receptor t cells targeting the tumor microenvironment
|
|
EP3615571A1
(en)
|
2017-04-24 |
2020-03-04 |
Ichnos Sciences SA |
T cell redirecting bispecific antibodies for the treatment of egfr positive cancers
|
|
MA48763A
(fr)
|
2017-05-05 |
2020-04-08 |
Amgen Inc |
Composition pharmaceutique comprenant des constructions d'anticorps bispécifiques pour un stockage et une administration améliorés
|
|
EP3635132A4
(en)
|
2017-06-07 |
2021-05-26 |
Intrexon Corporation |
EXPRESSION OF NOVEL CELL MARKERS
|
|
CN111247171A
(zh)
|
2017-10-14 |
2020-06-05 |
西托姆克斯治疗公司 |
抗体、可活化抗体、双特异性抗体和双特异性可活化抗体及其使用方法
|
|
MX2020006213A
(es)
|
2017-12-12 |
2020-09-14 |
Pionyr Immunotherapeutics Inc |
Anticuerpos anti-trem2 y metodos relacionados.
|
|
ES3068176T3
(en)
*
|
2018-02-12 |
2026-05-28 |
Massachusetts Gen Hospital |
Chimeric antigen receptor t cells targeting the tumor microenvironment
|
|
CN120399075A
(zh)
|
2018-03-14 |
2025-08-01 |
诺维莫尼公司 |
抗-CD3ε抗体及其应用方法
|
|
ES2914986T3
(es)
|
2018-03-16 |
2022-06-20 |
Univ Koeln |
Derivados de Lys-C(O)-Glu sustituidos con 2-alcoxi-6-[18F]fluoronicotinoilo como sondas eficaces para la obtención de imágenes de tejidos que expresan PSMA
|
|
EP3833444A1
(en)
*
|
2018-08-09 |
2021-06-16 |
Maverick Therapeutics, Inc. |
Coexpression and purification method of conditionally activated binding proteins
|
|
WO2020176897A1
(en)
|
2019-02-28 |
2020-09-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric antigen receptors and uses thereof
|
|
US20210128617A1
(en)
|
2019-08-27 |
2021-05-06 |
The Trustees Of The University Of Pennsylvania |
SYNTHETIC CARS TO TREAT IL13R-alpha-2 POSITIVE HUMAN AND CANINE TUMORS
|
|
CN111320694B
(zh)
*
|
2020-02-15 |
2022-07-22 |
广西科技大学 |
一种由重链抗体的可变区组成的纳米抗体gn2及其制备方法和应用
|
|
JP2023550148A
(ja)
|
2020-11-20 |
2023-11-30 |
シンシア・イノベーション・インコーポレイテッド |
がん免疫治療に用いられる武装二重car-t組成物及び方法
|